CT-based response assessment of advanced gastrointestinal stromal tumor: Dual energy CT provides a more predictive imaging biomarker of clinical benefit than RECIST or Choi criteria

European Journal of Radiology

Volumn 82, Issue 6, 2013, Pages 923-928

  Meyer, M ^a   Hohenberger, P ^a   Apfaltrer, P ^a   Henzler, T ^a   Dinter, D J ^a   Schoenberg, S O ^a   Fink, C ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Choi criteria; Dual energy CT; Gastro intestinal stromal tumor; RECIST; Therapy monitoring

Indexed keywords

BIOLOGICAL MARKER; IMATINIB; IODINE; NILOTINIB; SUNITINIB;

ADULT; ADVANCED GASTROINTESTINAL STROMAL TUMOR; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY COMPUTED TOMOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; PROTEIN-TYROSINE KINASES; RADIOGRAPHY, DUAL-ENERGY SCANNED PROJECTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84876891524     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2013.01.006     Document Type: Article

References (21)

1. G.D. Demetri, R.S. Benjamin, and C.D. Blanke NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)-update of the NCCN clinical practice guidelines Journal of the National Comprehensive Cancer Network 5 Suppl. 2 2007 S1 S29 quiz S30
2. G.D. Demetri, M. von Mehren, and C.D. Blanke Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors The New England Journal of Medicine 347 2002 472 480
3. R.S. Benjamin, H. Choi, and H.A. Macapinlac We should desist using RECIST, at least in GIST Journal of Clinical Oncology 25 2007 1760 1764
4. D. Vanel, M. Albiter, and L. Shapeero Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients European Journal of Radiology 54 2005 118 123
5. A. Le Cesne, M. Van Glabbeke, and J. Verweij Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial Journal of Clinical Oncology 27 2009 3969 3974
6. H. Choi, C. Charnsangavej, and S. de Castro Faria CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings AJR. American Journal of Roentgenology 183 2004 1619 1628
7. C.H. Holdsworth, R.D. Badawi, and J.B. Manola CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor AJR. American Journal of Roentgenology 189 2007 324 330
8. H. Choi Response evaluation of gastrointestinal stromal tumors Oncologist 13 Suppl. 2 2008 4 7
9. H. Choi, C. Charnsangavej, and S.C. Faria Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria Journal of Clinical Oncology 25 2007 1753 1759
10. G. Schmid-Bindert, T. Henzler, and T.Q. Chu Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT? European Radiology 22 2012 93 103
11. T.R. Johnson, B. Krauss, and M. Sedlmair Material differentiation by dual energy CT: initial experience European Radiology 17 2007 1510 1517
12. P. Apfaltrer, M. Meyer, and C. Meier Contrast-enhanced dual-energy CT of gastrointestinal stromal tumors: is iodine-related attenuation a potential indicator of tumor response? Investigative Radiology 47 2012 65 70
13. N. Schramm, M. Schlemmer, and E. Englhart Dual energy CT for monitoring targeted therapies in patients with advanced gastrointestinal stromal tumor: initial results Current Pharmaceutical Biotechnology 12 2011 547 557
14. R.E. Alvarez, and A. Macovski Energy-selective reconstructions in X-ray computerized tomography Physics in Medicine and Biology 21 1976 733 744
15. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) European Journal of Cancer 45 2009 228 247
16. O. Dudeck, M. Zeile, P. Reichardt, and D. Pink Comparison of RECIST and Choi criteria for computed tomographic response evaluation in patients with advanced gastrointestinal stromal tumor treated with sunitinib Annals of Oncology 22 2011 1828 1833
17. A.D. Van den Abbeele The lessons of GIST-PET and PET/CT: a new paradigm for imaging Oncologist 13 Suppl 2 2008 8 13
18. M. Schlemmer, S.P. Sourbron, and N. Schinwald Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy European Journal of Radiology 77 2011 312 318
19. U. De Giorgi, C. Aliberti, G. Benea, M. Conti, and M. Marangolo Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors Clinical Cancer Research 11 2005 6171 6176
20. N. Lassau, M. Lamuraglia, and D. Vanel Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 cases Annals of Oncology 16 2005 1054 1060
21. X. Hong, H. Choi, E.M. Loyer, R.S. Benjamin, J.C. Trent, and C. Charnsangavej Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib Radiographics 26 2006 481 495